![]() | Up a level |
Politopoulou, Konstantina, Mills, Mackenzie and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2023)
HTA255 First-in-class drugs in HTA: blunder or bliss?
Value in Health, 26 (12).
S369 - S369.
ISSN 1098-3015
Gill, Jennifer L, Miracolo, Aurelio, Politopoulou, Konstantina, Jayawardana, Sahan ORCID: 0000-0001-7081-3910, Apostolou, Efstratios A., Carter, Alex
ORCID: 0000-0003-3793-407X and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2023)
MSR1 Estimating lifetime benefits of optimizing secondary preventive treatment for atherosclerotic cardiovascular disease.
Value in Health, 26 (12).
S393 - S393.
ISSN 1098-3015
Gill, Jennifer, Miracolo, Aurelio, Politopoulou, Konstantina, Jayawardana, Sahan ORCID: 0000-0001-7081-3910, Carter, Alex
ORCID: 0000-0003-3793-407X, Apostolou, Efstratios A. and Kanavos, Panos
ORCID: 0000-0001-9518-3089
(2023)
How can we improve secondary prevention of cardiovascular disease?
.
Medical Technology Research Group (MTRG), The London School of Economics and Political Science, London, UK.
Kamphuis, Bregtje, Fontrier, Anna-Maria, Haig, Madeleine, Politopoulou, Konstantina, Salyga, Hana, Gentilini, Arianna and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2021)
Development of policies to increase headroom for innovation in Egypt and the Kingdom of Saudi Arabia.
.
LSE Consulting, London, UK.